Cellular and molecular basis of pulmonary arterial hypertension. - Wikidata - wikimedia - TriplyDB

Cellular and molecular basis of pulmonary arterial hypertension.

Cellular and molecular basis of pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37465320

about

Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutations Pulmonary Hypertension and Indicators of Right Ventricular Function The molecular targets of approved treatments for pulmonary arterial hypertension Molecular mechanisms of pulmonary arterial remodeling The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis Schistosomiasis-associated pulmonary hypertension Arrhythmias in pulmonary arterial hypertension Tenascin-C in development and disease of blood vessels Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy Pulmonary arterial hypertension associated with congenital heart disease and Eisenmenger syndrome: current practice in pediatrics Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension Ambrisentan Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension Interactions among vascular-tone modulators contribute to high altitude pulmonary edema and augmented vasoreactivity in highlanders A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Molecular imaging of the human pulmonary vascular endothelium in pulmonary hypertension: a phase II safety and proof of principle trial.ANG-1 TIE-2 and BMPR signalling defects are not seen in the nitrofen model of pulmonary hypertension and congenital diaphragmatic hernia.Sex differences in the pulmonary circulation: implications for pulmonary hypertension Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca(2+) entry in human pulmonary arterial smooth muscle cells Recapitulation of developing artery muscularization in pulmonary hypertension.Role of Transient Receptor Potential Channels in Heart Transplantation: A Potential Novel Therapeutic Target for Cardiac Allograft Vasculopathy.Assessment of microRNA and gene dysregulation in pulmonary hypertension by endoarterial biopsy.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.The Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary Vasculature Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease.Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension.Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Genetics of pulmonary hypertension New trial designs and potential therapies for pulmonary artery hypertension.NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling.Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses Pulmonary arterial hypertension in Saudi Arabia: Patients' clinical and physiological characteristics and hemodynamic parameters. A single center experience.Frequency of edema in patients with pulmonary arterial hypertension receiving ambrisentan.

P2860

Q21133932-E3E15E2C-832C-4613-9160-A6B4C538C216 Q24303490-49BE600D-4053-4BA1-BEC8-A445C35CDD8E Q26744781-C3D11527-E213-415A-9032-0992CD4DD063 Q26798308-936324EC-233A-4F4D-85BC-A187BFCCBAAA Q26991806-1950F161-B31A-476B-A71D-FE55CFAC3E07 Q27005980-D3872633-FA5D-44F8-8143-94B607B30129 Q27006491-65E0049A-BBF0-44A5-8D19-D8E7C824E999 Q27025034-2836CDF0-1C25-45C6-B263-ED69B40FCCD8 Q27027610-271AA0BE-8B80-405A-9FBF-05528594670E Q27304673-48BF723D-C0B9-46DB-A51D-D19A6A17F610 Q28084598-390D4B32-D2CA-4944-8F1E-94D0A4FA0F0A Q28085572-C39D0F7E-B115-4E99-A7AC-FEA439EFB57C Q28109687-D81FC131-7D5D-4020-896E-D8A13FEC1D97 Q28114802-D48332D4-A659-4DAA-AE79-2AED9140C6CD Q28238985-6E36B044-778F-4A93-9399-108C923A4D03 Q28388333-E3482B25-489D-4931-B2F6-AC993D3548FC Q28483668-FA2A422D-7057-413A-9360-82C94FBBA3FD Q30544892-8E03B744-EC4D-4C0E-A988-B38AD6E7F8FC Q30851205-DFC53237-9AA1-484A-924B-821B124C288C Q31059736-B0CA4B2E-CDC8-49F0-9610-C5833586506E Q33568826-2065405B-B8D8-4ADA-A42B-A927C6B7A383 Q33569395-09AF5CF8-0B43-48C3-8486-A76A53660FD7 Q33587457-AB282486-B430-447F-BCEF-9B77EBD69A21 Q33727090-E350F92B-F9E4-4CA7-8916-FDF2BF3BF4E4 Q33788516-64512699-F412-41F9-B717-91D4FF82AFC2 Q33803027-12128B66-EDCC-407B-B595-B350207EA70C Q33804336-31304E8A-A353-46BE-8E52-04A3BAD21CD5 Q33805932-5CA1E7BE-FC4C-46F5-B0BF-399D261742E7 Q33806024-4B8903C0-751B-44E9-99EE-AB53E493810F Q33806253-12C1D808-5AFA-4D23-B363-5E401DBD69BE Q33859158-BDD9496E-475E-4B38-857D-DAF43A525526 Q33891553-E93BD596-BD76-4408-9B85-25F306F58531 Q33925149-EC5DB40E-5B5E-43A6-A8E5-8EF03DBA180A Q33965854-20F18CDE-05D8-473D-80B5-D919FF2BE54E Q33982467-75987022-F266-44CA-9402-611B82278EB3 Q34025109-8D7679D3-4D6F-4EE0-8D9F-6E27AA99811E Q34062962-405EDAC6-BC19-47DC-BFBB-DD3FE121923E Q34095714-460224EB-89AB-45E3-8235-34DE54F3C97B Q34197167-E83A6A9A-AD22-4A72-BF0D-4EC6885B2FF1 Q34205555-E593D4D5-AF32-4AA7-A310-855A511FF784

P2860

Cellular and molecular basis of pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37465320

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cellular and molecular basis of pulmonary arterial hypertension.

@en

Cellular and molecular basis of pulmonary arterial hypertension.

@nl

type

label

Cellular and molecular basis of pulmonary arterial hypertension.

@en

Cellular and molecular basis of pulmonary arterial hypertension.

@nl

prefLabel

Cellular and molecular basis of pulmonary arterial hypertension.

@en

Cellular and molecular basis of pulmonary arterial hypertension.

@nl

P1433

Q37465320-FAB72D8F-16DB-4AC9-ADD6-75DE730C5910

P1476

Q37465320-EF548892-9E5A-4D97-B518-508B38E6A25B

P2093

Q37465320-10F3211B-D16E-40EA-981B-89419DDA6706

Q37465320-3504FB53-2124-4473-BA66-06930342EE31

Q37465320-4EF3AA69-CCC3-4E8A-B9AD-004CA008D7CF

Q37465320-4F8CB79E-D3A9-434B-AB8E-5EC448053F69

Q37465320-7E26AE2B-0821-41A4-8A16-B976BDA942E8

Q37465320-8E5B04C6-3D55-48B9-9D91-EFC36A5F51F9

Q37465320-CB393DDC-DE5B-4AB0-A6A1-F9DA3D4317F2

Q37465320-CBD6580E-76E8-4FAD-BB6B-B6D5CD0085A9

P2860

Q37465320-0036508A-4315-4FD7-84DE-E7973F286C25

Q37465320-0294B4C4-3FA8-4366-AC40-9F58127C0D67

Q37465320-07B4D1A3-1C96-4082-8E9A-90938C98CEB3

Q37465320-085DF6C9-DF17-4B2B-BC77-23FF3103B670

Q37465320-0A462494-72A0-4E89-B3E1-E1AE98AEDDCE

Q37465320-0E18C55A-A3F8-4D44-B659-3116187BF284

Q37465320-1105763F-5A58-4F38-97DD-23609589BE76

Q37465320-1282112C-C692-4FB0-A75E-0A6A5461B3B2

Q37465320-12F563C9-A9DD-476E-B035-0C73160DC92C

Q37465320-13B3A720-ED50-4C34-84B8-2889AA7B5AAA

P304

Q37465320-F162671B-54E8-4B33-BE29-554095D5EB9C

P31

Q37465320-B0A8E0C4-F19B-4133-B9D0-3C342165B6E2

P356

Q37465320-2A38E828-6569-4AB2-9510-08DE99417D0E

P407

Q37465320-B5CE8E22-1140-4EED-9BDB-42C390336F7A

P433

Q37465320-2E1A583F-6D6A-48DC-BC39-40E30ED9C598

P478

Q37465320-B077B28E-E2D0-4E7D-B3B0-A04D5DC64C92

P50

Q37465320-88462650-F118-45C6-B39F-F2398F4DB333

Q37465320-8F6A4498-6419-41F0-BE70-67D78EE188A5

Q37465320-B596EF1B-A770-49AD-A618-15F7BEC887F4

Q37465320-D459E800-6907-45E5-8167-18AA91491232

P577

Q37465320-83EECE1D-9986-4D3C-9F5A-E702ADE04D16

P5875

Q37465320-54FE695A-2392-4476-8291-04C843C62C05

P698

Q37465320-B579E679-E326-438A-8135-8871D4FCDED9

P921

Q37465320-F3F738CF-5C1A-4E0C-AE65-AB49E590A3DC

P932

Q37465320-F6EDBED8-7FA5-4FAD-A750-E1EC59AB4AD2

P356

J.JACC.2009.04.018

P1433

Journal of the American College of Cardiology

P1476

Cellular and molecular basis of pulmonary arterial hypertension.

@en

P2093

E Kenneth Weir

http://www.w3.org/2001/XMLSchema#string

Ivan F McMurtry

http://www.w3.org/2001/XMLSchema#string

Jason X-J Yuan

http://www.w3.org/2001/XMLSchema#string

Kurt R Stenmark

http://www.w3.org/2001/XMLSchema#string

Margaret R MacLean

http://www.w3.org/2001/XMLSchema#string

Patricia A Thistlethwaite

http://www.w3.org/2001/XMLSchema#string

Peter Lloyd Jones

http://www.w3.org/2001/XMLSchema#string

Stephen L Archer

http://www.w3.org/2001/XMLSchema#string

P2860

Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension

Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells

Cloning and characterization of a human type II receptor for bone morphogenetic proteins

Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth

The myofibroblast: one function, multiple origins

Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis

Rho GTPases: biochemistry and biology

Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase

Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment

P304

S20-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2009.04.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

1 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Norbert Weissmann

Nicholas W Morrell

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51437088

http://www.w3.org/2001/XMLSchema#string

P698

19555855

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

2790324

http://www.w3.org/2001/XMLSchema#string